DBV Technologies Future Growth
Future criteria checks 3/6
DBV Technologies is forecast to grow earnings and revenue by 53.3% and 7.3% per annum respectively while EPS is expected to grow by 30.6% per annum.
Key information
53.3%
Earnings growth rate
30.6%
EPS growth rate
Biotechs earnings growth | 23.5% |
Revenue growth rate | 7.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 25 Mar 2024 |
Recent future growth updates
No updates
Recent updates
FDA puts partial clinical hold on a DBT Technologies peanut allergy patch phase 3 trial
Sep 21DBV Technologies GAAP EPS of -$0.35 misses by $0.03, revenue of $1.53M beats by $0.29M
Aug 01DBV Technologies: Good Data, Plenty Of Cash And Regulatory Uncertainty
Jul 07DBV Technologies reports change in U.S. reporting status, cuts headcount
Jan 07DBV Technologies CSO Hugh Sampson to step down from role
Nov 24DBV Technologies shares rockets 85% as EMA approves Viaskin Peanut application
Nov 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 22 | 6 | 13 | N/A | 1 |
12/31/2025 | 5 | -80 | -115 | N/A | 1 |
12/31/2024 | 7 | -116 | -187 | N/A | 2 |
12/31/2023 | 16 | -73 | -80 | -80 | N/A |
9/30/2023 | 6 | -101 | -90 | -90 | N/A |
6/30/2023 | 5 | -101 | -91 | -90 | N/A |
3/31/2023 | 4 | -100 | -76 | -75 | N/A |
12/31/2022 | 5 | -96 | -56 | -56 | N/A |
9/30/2022 | 9 | -71 | -52 | -51 | N/A |
6/30/2022 | 8 | -77 | -55 | -53 | N/A |
3/31/2022 | 5 | -85 | -74 | -74 | N/A |
12/31/2021 | 6 | -98 | -109 | -108 | N/A |
9/30/2021 | 2 | -124 | -124 | -123 | N/A |
6/30/2021 | 4 | -131 | -144 | -142 | N/A |
3/31/2021 | 9 | -148 | -154 | -152 | N/A |
12/31/2020 | 11 | -160 | -168 | -166 | N/A |
9/30/2020 | 17 | -161 | -157 | -153 | N/A |
6/30/2020 | 16 | -171 | -156 | -151 | N/A |
3/31/2020 | 16 | -169 | -161 | -156 | N/A |
12/31/2019 | 15 | -172 | -154 | -148 | N/A |
9/30/2019 | 12 | -176 | -156 | -151 | N/A |
6/30/2019 | 13 | -198 | -176 | -169 | N/A |
3/31/2019 | 13 | -191 | -166 | -160 | N/A |
12/31/2018 | 13 | -190 | -162 | -157 | N/A |
9/30/2018 | 11 | -178 | -164 | -157 | N/A |
6/30/2018 | 11 | -172 | -150 | -145 | N/A |
3/31/2018 | 11 | -182 | -154 | -147 | N/A |
12/31/2017 | 12 | -177 | -146 | -137 | N/A |
9/30/2017 | 11 | -169 | N/A | -118 | N/A |
6/30/2017 | 11 | -157 | N/A | -97 | N/A |
3/31/2017 | 9 | -135 | N/A | -77 | N/A |
12/31/2016 | 8 | -121 | N/A | -63 | N/A |
9/30/2016 | 8 | -109 | N/A | -58 | N/A |
6/30/2016 | 8 | -88 | N/A | -49 | N/A |
3/31/2016 | 8 | -72 | N/A | -41 | N/A |
12/31/2015 | 7 | -49 | N/A | -29 | N/A |
9/30/2015 | 6 | -40 | N/A | -28 | N/A |
6/30/2015 | 6 | -30 | N/A | -25 | N/A |
3/31/2015 | 5 | -27 | N/A | -23 | N/A |
12/31/2014 | 6 | -29 | N/A | -25 | N/A |
9/30/2014 | 6 | -30 | N/A | -24 | N/A |
6/30/2014 | 7 | -32 | N/A | -25 | N/A |
3/31/2014 | 6 | -28 | N/A | -21 | N/A |
12/31/2013 | 5 | -27 | N/A | -18 | N/A |
9/30/2013 | 4 | -23 | N/A | -16 | N/A |
6/30/2013 | 4 | -20 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DBVT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: DBVT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: DBVT is expected to become profitable in the next 3 years.
Revenue vs Market: DBVT's revenue (7.3% per year) is forecast to grow slower than the US market (8.2% per year).
High Growth Revenue: DBVT's revenue (7.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DBVT's Return on Equity is forecast to be high in 3 years time